These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31536166)

  • 1. CHI3L1 promotes proliferation and improves sensitivity to cetuximab in colon cancer cells by down-regulating p53.
    Liu K; Jin M; Ye S; Yan S
    J Clin Lab Anal; 2020 Jan; 34(1):e23026. PubMed ID: 31536166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of Chitinase 3-Like-1 Inhibits Cell Proliferation, Promotes Apoptosis, and Enhances Effect of Anti-Programmed Death Ligand 1 (PD-L1) in Diffuse Large B Cell Lymphoma Cells.
    Yang X; Fang D; Li M; Chen J; Cheng Y; Luo J
    Med Sci Monit; 2021 Mar; 27():e929431. PubMed ID: 33764958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis.
    Park KR; Yun HM; Yoo K; Ham YW; Han SB; Hong JT
    Cell Commun Signal; 2020 Mar; 18(1):5. PubMed ID: 32127023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
    Kim KC; Yun J; Son DJ; Kim JY; Jung JK; Choi JS; Kim YR; Song JK; Kim SY; Kang SK; Shin DH; Roh YS; Han SB; Hong JT
    Theranostics; 2018; 8(16):4409-4428. PubMed ID: 30214629
    [No Abstract]   [Full Text] [Related]  

  • 5. Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer.
    Kawada M; Seno H; Kanda K; Nakanishi Y; Akitake R; Komekado H; Kawada K; Sakai Y; Mizoguchi E; Chiba T
    Oncogene; 2012 Jun; 31(26):3111-23. PubMed ID: 22056877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kruppel-like factor 2 mediated anti-proliferative and anti-metastasis effects of simvastatin in p53 mutant colon cancer.
    Lu L; Huang W; Hu W; Jiang L; Li Y; Wu X; Yuan D; Li M
    Biochem Biophys Res Commun; 2019 Apr; 511(4):772-779. PubMed ID: 30833076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MT1G Regulates c-MYC/P53 Signal to Inhibit Proliferation, Invasion and Migration and Promote Apoptosis in Colon Cancer Cells.
    Li J; Hu Q; Li Z; Feng K; Li K
    Curr Mol Med; 2024; 24(3):379-388. PubMed ID: 36999424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitinase 3-like 1 induces survival and proliferation of intestinal epithelial cells during chronic inflammation and colitis-associated cancer by regulating S100A9.
    Low D; Subramaniam R; Lin L; Aomatsu T; Mizoguchi A; Ng A; DeGruttola AK; Lee CG; Elias JA; Andoh A; Mino-Kenudson M; Mizoguchi E
    Oncotarget; 2015 Nov; 6(34):36535-50. PubMed ID: 26431492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.
    Nayak KB; Kuila N; Das Mohapatra A; Panda AK; Chakraborty S
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1568-76. PubMed ID: 23665236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHI3L1 (Chitinase 3 Like 1) upregulation is associated with macrophage signatures in esophageal cancer.
    Huang J; Gu Z; Xu Y; Jiang L; Zhu W; Wang W
    Bioengineered; 2021 Dec; 12(1):7882-7892. PubMed ID: 34612767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal microRNAs derived from colon cancer cells promote tumor progression by suppressing fibroblast TP53 expression.
    Yoshii S; Hayashi Y; Iijima H; Inoue T; Kimura K; Sakatani A; Nagai K; Fujinaga T; Hiyama S; Kodama T; Shinzaki S; Tsujii Y; Watabe K; Takehara T
    Cancer Sci; 2019 Aug; 110(8):2396-2407. PubMed ID: 31148360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenomethionine induces p53 mediated cell cycle arrest and apoptosis in human colon cancer cells.
    Goel A; Fuerst F; Hotchkiss E; Boland CR
    Cancer Biol Ther; 2006 May; 5(5):529-35. PubMed ID: 16627976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells.
    Lin HW; Chiang YC; Sun NY; Chen YL; Chang CF; Tai YJ; Chen CA; Cheng WF
    Endocr Relat Cancer; 2019 Jan; 26(1):73-88. PubMed ID: 30121622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
    Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma.
    Luo D; Chen H; Lu P; Li X; Long M; Peng X; Huang M; Huang K; Lin S; Tan L; Zhu Y; Chen Z; Ouyang N; Li H
    Cancer Biomark; 2017; 18(3):273-284. PubMed ID: 28009325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1.
    Mussnich P; Rosa R; Bianco R; Fusco A; D'Angelo D
    Expert Opin Ther Targets; 2015; 19(8):1017-26. PubMed ID: 26107137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.
    Troiani T; Martinelli E; Napolitano S; Vitagliano D; Ciuffreda LP; Costantino S; Morgillo F; Capasso A; Sforza V; Nappi A; De Palma R; D'Aiuto E; Berrino L; Bianco R; Ciardiello F
    Clin Cancer Res; 2013 Dec; 19(24):6751-65. PubMed ID: 24122793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1.
    Huang YS; Jie N; Zhang YX; Zou KJ; Weng Y
    Int J Mol Med; 2018 Mar; 41(3):1397-1408. PubMed ID: 29286138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.